These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1453337)

  • 1. Can HIV-1 infection be transmitted by a "discarded" syringe?
    Montella F; Di Sora F; Recchia O
    J Acquir Immune Defic Syndr (1988); 1992 Dec; 5(12):1274-5. PubMed ID: 1453337
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis B prevention and risk of HIV infection in children injured by discarded needles and/or syringes].
    Aragón Peña AJ; Arrazola Martínez MP; García de Codes A; Dávila Alvarez FM; de Juanes Pardo JR
    Aten Primaria; 1996 Feb; 17(2):138-40. PubMed ID: 8948755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission of HIV among drug addicts in three French cities: implications for prevention.
    Ingold FR; Toussirt M
    Bull Narc; 1993; 45(1):117-34. PubMed ID: 8305902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid assessment of injection practices in Cambodia, 2002.
    Vong S; Perz JF; Sok S; Som S; Goldstein S; Hutin Y; Tulloch J
    BMC Public Health; 2005 Jun; 5():56. PubMed ID: 15929800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the number of HIV transmissions through reused syringes and needles in the Mbeya Region, Tanzania.
    Hoelscher M; Riedner G; Hemed Y; Wagner HU; Korte R; von Sonnenburg F
    AIDS; 1994 Nov; 8(11):1609-15. PubMed ID: 7848599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
    Lurie P; Gorsky R; Jones TS; Shomphe L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Accidental HIV exposure of children through injury with discarded syringes].
    Blanche S
    Arch Pediatr; 2000 Jan; 7(1):83-6. PubMed ID: 10668092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HIV-infected syringes during a syringe-exchange program.
    Heimer R; Kaplan EH; Cadman EC
    N Engl J Med; 1992 Dec; 327(26):1883-4. PubMed ID: 1448131
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado.
    Lewis BA; Koester SK; Bush TW
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S46-51. PubMed ID: 12489615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difficulty accessing syringes and syringe borrowing among injection drug users in Bangkok, Thailand.
    Kerr T; Fairbairn N; Hayashi K; Suwannawong P; Kaplan K; Zhang R; Wood E
    Drug Alcohol Rev; 2010 Mar; 29(2):157-61. PubMed ID: 20447223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential for HIV transmission through unsafe injections.
    Apetrei C; Becker J; Metzger M; Gautam R; Engle J; Wales AK; Eyong M; Enyong P; Sama M; Foley BT; Drucker E; Marx PA
    AIDS; 2006 Apr; 20(7):1074-6. PubMed ID: 16603865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
    Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
    Pollini RA
    J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk behaviors for HIV transmission among the recent clients of a syringe-exchange program in Madrid, 1993].
    Bravo Portela MJ; Barrio Anta G; de la Fuente de Hoz L; Colomo Gómez C; Royuela Morales L; Estébanez Estébanez P
    Gac Sanit; 1996; 10(57):261-73. PubMed ID: 9072510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV incidence among injecting drug users in New York City syringe-exchange programmes.
    Des Jarlais DC; Marmor M; Paone D; Titus S; Shi Q; Perlis T; Jose B; Friedman SR
    Lancet; 1996 Oct; 348(9033):987-91. PubMed ID: 8855855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection risks and HIV transmission in the Republic of South Africa.
    Reid S; Van Niekerk AA
    Int J STD AIDS; 2009 Dec; 20(12):816-9. PubMed ID: 19948894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringe and needle exchange as HIV/AIDS prevention for injection drug users.
    Watters JK; Estilo MJ; Clark GL; Lorvick J
    JAMA; 1994 Jan; 271(2):115-20. PubMed ID: 8264065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
    Wright-De Agüero L; Weinstein B; Jones TS; Miles J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection and syringe sharing among HIV-infected injection drug users: implications for prevention of HIV transmission. Supplement to HIV/AIDS Surveillance Group.
    Diaz T; Chu SY; Weinstein B; Mokotoff E; Jones TS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S76-81. PubMed ID: 9663628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.